Authors:
Maung, HM
Elangovan, L
Frazao, JM
Bower, JD
Kelley, BJ
Acchiardo, SR
Rodriguez, HJ
Norris, KC
Sigala, JF
Rutkowski, M
Robertson, JA
Goodman, WG
Levine, BS
Chesney, RW
Mazess, RB
Kyllo, DM
Douglass, LL
Bishop, CW
Coburn, JW
Citation: Hm. Maung et al., Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1 alpha-hydroxyvitamin D-2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison, AM J KIDNEY, 37(3), 2001, pp. 532-543
Authors:
Frazao, JM
Elangovan, L
Maung, HM
Chesney, RW
Acchiardo, SR
Bower, JD
Kelley, BJ
Rodriguez, HJ
Norris, KC
Robertson, JA
Levine, BS
Goodman, WG
Gentile, D
Mazess, RB
Kyllo, DM
Douglass, LL
Bishop, CW
Coburn, JW
Citation: Jm. Frazao et al., Intermittent doxercalciferol (1 alpha-hydroxyvitamin D-2) therapy for secondary hyperparathyroidism, AM J KIDNEY, 36(3), 2000, pp. 550-561
Citation: L. Elangovan et al., Spontaneous resolution and recurrence of hypercalcemia in primary hyperparathyroidism - anecdotal observations with potential implications for parathyroid pathophysiology in renal disease, NEPH DIAL T, 14(10), 1999, pp. 2323-2327